Genetic deletion of Th2 or M2 inducers increases the risk for metabolic disorders (56), and M2 macrophage infusion into obese mice has proven to be effective in treating obesity and improving insulin sensitivity (57). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.